Integrated Management of Pronation Deformity in Cerebral Palsy

NCT ID: NCT03472261

Last Updated: 2020-04-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-26

Study Completion Date

2020-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pronation deformity is a very common problem in children with cerebral palsy. This deformity is usually has neural and non-neural aspects. In this clinical trial the aim is to show the importance of combine treatment approach with pharmacological and non-pharmacological modalities. .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Spasticity is not only the most common motor disorder but also the main cause of slowly developing contractures in children with cerebral palsy. Pronation deformity which is a very common problem in children with cerebral palsy is primarily due to spasticity of the pronator muscles. Reduced strength and loss of control of the supinator muscles and soft tissue and joint contractures usually coexist with spasticity of pronator muscles. There is very limited information about how to treat this deformity in the current literature.

In this prospective, randomized, controlled clinical trial the aim is to show the effectiveness of twister, and home exercise program in an integrated approach with BoNT-A injections on spasticity, and passive range of motion (pROM) of children with CP having pronation deformity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group

Patients treated by Botulinum toxin A and twister and specific home exercise program

Group Type EXPERIMENTAL

Botulinum toxin type A

Intervention Type DRUG

Dysport

Upper extremity orthoses

Intervention Type OTHER

Twister

Home exercise program

Intervention Type OTHER

Specific exercises for pronation deformity

Conventional Therapy Group

Patients treated by Botulinum toxin A and specific home exercise program

Group Type ACTIVE_COMPARATOR

Botulinum toxin type A

Intervention Type DRUG

Dysport

Home exercise program

Intervention Type OTHER

Specific exercises for pronation deformity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Botulinum toxin type A

Dysport

Intervention Type DRUG

Upper extremity orthoses

Twister

Intervention Type OTHER

Home exercise program

Specific exercises for pronation deformity

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of cerebral palsy
* MAS score of pronator muscles at least 2
* Gross Motor Functional Classification Scale level of I-IV
* Scheduled to receive botulinum toxin injections to pronator teres and/or -pronator quadratus muscles besides other spastic upper extremity muscles

Exclusion Criteria

* Severe cognitive or behavioural problems
* Less than 40 degrees of available passive range of motion in pronation
* Severe dystonia in the affected upper limb
* Received orthopedic surgery to affected upper limb
Minimum Eligible Age

2 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kocaeli University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nigar Dursun

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Melike Akarsu, MSc

Role: PRINCIPAL_INVESTIGATOR

Kocaeli University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kocaeli University

Kocaeli, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KU GOKAEK 2018/8

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.